The Protégé study will further evaluate the safety of teplizumab and test whether it will reduce or prevent the autoimmune attack that damages beta cells.
To be in the Protégé study, you must:
- Be 8 to 35 years of age
- Have had your first visit to a doctor for symptoms of type 1 diabetes and received that diagnosis within 12 weeks of starting treatment on this study
- Weigh at least 36 kg (79 lbs)
- Not be using any other experimental treatment during the time you are in the study
- Not have received treatment with a monoclonal antibody within 1 year before joining the study
- Not currently be using or planning to use inhaled insulin
- Not have received a vaccination with a live virus within 12 weeks before joining the study
If you are interested in participating in this study, please visit www.protegediabetes.org or contact Amy Knesel at aknesel@mmgct.com.
February 19, 2008
[ Back to Studies Page ]
|
|
|
|
| |
 |
 |
|
|
|
Last Updated: Sun Apr 13 10:33:24 2008
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by Children With Diabetes, Inc, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice and Privacy Policy.
© Children with Diabetes, Inc. 1995-2009. Comments and Feedback.
